chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After first injection, I felt that my left rotary cuff tore. Then my right starting to feel the same. Went to Doctor, got Xray and initial assessment with only minor arthritis. But could not tell why the pain unless it was a tear. I describe this as sever joint pain at the rotarty cuff. Symptoms got better (not fully resolved) before next immunization. After 2nd shot, the next day my joint on the shoulder hurt but then my knee (which I have lived with out a ACL hurt a ton and swelled up). I also noticed muscle pain on the extremities and joint pain and minor swelling on finger joints. I do not have a history of arthritis and not prevalent in my family history.
nausea; GI upset; chills; low grade fever; Diarrhea (mild); booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 18Nov2021 11:30 (Lot number: EW0196, Expiration Date: Dec2021) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "hypothyroid", start date: 2005 (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism, start date: 2005 (ongoing). Vaccination history included: Bnt162b2 (Dose 1, Date: 25Feb2021, Time: Unk, anatomical site of injection: Right arm, Batch/lot number: EL3247), administration date: 25Feb2021, when the patient was 50 years old, for COVID-19 Immunization; Bnt162b2 (Dose 2, Date: 18Mar2021, Time: Unk, anatomical site of injection: Right arm, Batch/lot number: EL3247), administration date: 18Mar2021, when the patient was 50 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 18Nov2021 11:30, outcome "unknown", described as "booster"; NAUSEA (non-serious) with onset 19Nov2021 11:30, outcome "recovered" (21Nov2021), described as "nausea"; ABDOMINAL DISCOMFORT (non-serious) with onset 19Nov2021 11:30, outcome "recovered" (21Nov2021), described as "GI upset"; CHILLS (non-serious) with onset 19Nov2021 11:30, outcome "recovered" (21Nov2021), described as "chills"; PYREXIA (non-serious) with onset 19Nov2021 11:30, outcome "recovered" (21Nov2021), described as "low grade fever"; DIARRHOEA (non-serious) with onset 19Nov2021 11:30, outcome "recovered" (21Nov2021), described as "Diarrhea (mild)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of nausea, abdominal discomfort, chills, pyrexia, diarrhoea.  No follow-up attempts are possible. No further information is expected.
Fever to 101.3, sustained chills, and local/injection site pain. Lightheadedness. Onset 22 hours after injection.
I have been feeling a real sick; Headache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Jun2021 as dose 1, single for covid-19 immunisation. The patient medical history was none. The patient concomitant medications were not reported. On an unknown date in Jun2021, the patient has been feeling a real sick and had headache. Reportedly, patient was on day 5 after first shot (Unspecified Shot) here for the Covid thing and had been feeling a real sick. Patient was little better today, just had a headache and was just wondering if that was normal as patient was on day 5. The outcome of the events was unknown.  Follow-up attempts are needed. Information on the lot/batch number has been requested.
Vulvar ulcers (Lipschutz ulcers) on labia majora, minora, introitus, and on urinary meatus; Prednisone dose pack for 7 days; lidocaine gel; resolved by 2/06/2021
Pt recvd booster dose of MMR on 08AUG90; 10 min p/vax pt exp wheezing, light-headedness, & chest pain; tx Epi & DPH;
I had multisymptom inflammatory syndrome that lasted about a month, beginning in April of 2022. I went to urgent care on April 22, 2022, the day I had the positive COVID-19 test.  I was already on steroids for Colitis, which I think helped, over the counter decongestants and Tylenol. They did prescribe Paxlovid but my pharmacy did not have it.  The doctor said if I got worse to pick up the script.  I never did pick it up or take it.
Blurry vision, dizziness, weakness.   Has continued and worsened. Can not see to 10 feet, and has worsened to 4 feet. Heart rate 160, unable to function
Information has been received from a consumer concerning a 9 year old male who in 1995 was vaccinated with varicella vaccine. On 04/17/2001 the pt experienced 400-500 lesions all over his body, except face and arms. The pt has no fever and no itching. The pt sought medical attention. It was also noted that the pt's sibling had a similar experience. Additional info has been requested.
Information has been received from a pharmacist referring to a patient of unknown age and gender. On 03-DEC-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # L031273, expiration date 19-NOV-2016, dose and route unknown). On 12-JAN-2016, the same patient inadvertently received another dose of ZOSTAVAX (lot # L031273, expiration date 19-NOV-2016, dose and route unknown) (extra dose administered). No adverse effects were reported. Additional information has been requested.
Sore throat / severe sore throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat / severe sore throat) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat / severe sore throat). The patient was treated with PARACETAMOL (TYLENOL) for Sore throat, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Sore throat, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Sore throat / severe sore throat) outcome was unknown.            Concomitant medications included unspecified blood pressure medication. Action taken with mRNA-1273 in response to the events was not applicable.
On April 1, 2021, I started developing a rash on the upper areas of my body.  It was was itchy. small red bumps.  On April 2, I went to my primary doctor and he prescribed  Hydroxyzine Hcl 50/mg.   The next morning,  the rash was all over my body, from my head to my toes, in my ears, in my hair.  So I went to UMC Urgent Care to see a Dr.   The Dr. stated that is was mostly from the vaccine.  The Dr. took a Covid test and it came back negative.  On April 5,2021, I went to my Dermatologist, they they took a biopsy.   My Dermatologist has indicated that I should not take the second shot.  I was given Prednisone 10/mg and Triamcinolone 0.1% 15/mg.
patient got moderna vaccine (both dose 1 and 2) even though he is not 18 years old yet. he showed no signs of symptoms or adverse effects.
Red swollen area around injection site  irritated; Red swollen area around injection site; Swollen injection site; Red swollen area around injection site itches; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER2613), via an unspecified route of administration in the left arm (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202), via an unspecified route of administration in the left arm on 01Mar2021, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 13:00, the patient experienced red swollen area around injection site. Developed about a week after the injection. It was also itchy and irritated. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of red swollen area around injection site, swollen injection site, red swollen area around injection site itches and red swollen area around injection site irritated was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
minor sore throat; This is a spontaneous report from a contactable 72-year-old (age at vaccination) male consumer reported for himself that he received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number; unknown, Not available/provided to reporter at the time of report completion) on 22Jan2021 at 11:15 am at 1st dose single on right arm for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was reported as hospital. Patient's medical history was not reported (other medical history no health issues, allergies to medications, food, or other products; no). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. The patient was experiencing minor sore throat for past three days beginning day 9 (30Jan2021). No treatment was received for the adverse event. The reported events were not considered as serious and did not fall under any seriousness criteria. The outcome of event was not recovered.   Follow-up attempts completed. No further information expected.
June 6, 2012 began with fever of 101.8. Took patient to doctor the next day with no outward signs or symptoms of anything wrong. Fever continued through June 8, 2012 controlled by Advil. Fever never raised above 101.8 but stayed in that range when Advil would wear off. Fever broke June 9, 2012. Rash over chest, stomach, back and proximal extremities developed. No further fever. Rash remains as of 09:16PM June 10, 2012.
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 4/27/2023 ARTHRITIS OF LEFT GLENOHUMERAL JOINT G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 4/27/2023 SEPTIC SHOCK
Patient received vaccine and waited for 15 minutes. Got up afterword said he felt "hot" and fell forward onto his knees. Rolled onto his face/mouth. Was passed out for about 3-4 seconds. Sat up and rested for
ED visit / hospitalization within 6 weeks of COVID vaccine: ED 3/14/21; ED 3/15/21; ED 3/30/21; Hospitalization 3/31/21
Severe chills, then sweating, headache, body aches, severe fatigue lasting 24 hours for both doses.
Patient was given 0.5mL of the Moderna Bivalent covid vaccine instead of 0.5mL of the Moderna covid-10 vaccine (primary series). no none symptoms
Nursing note from 12/4/11 at 2:40pm - Pt notified writer at this time that her left arm has an area of redness, swelling and tenderness. Site is at left deltoid and pt reports she had received a pneumonia vaccine to this location 12/3/2011. Site is erythemic, swollen and tender to touch. Dr immediately notified and one-time order given for Ibuprofen 400mg PO which was administered to the pt. ADR reported on 12/13/11 by primary care nurse practitioner: band like rash 6cm around area of injection.
Pt revcd immun 26Mar91.Sx began approx 4 hrs /p immun.Mom described as blotchey& more hived than rashy.T 103(R).Funny high pitched cry off & on for 3 hrs. Mom gave APAP rt /p immun.High T @ noc & into next day dropping by evening...see WORM
Fever, chills, vomiting, fatigue for 2 days following the 2nd dose.    On Sunday Feb 28th she had cellulitis to the injection area that was red, swollen and getting larger. .   She went to UTC and was given antibiotics for cellulitis.   She then had fatigue for the week of March 1.   On March 20th she went to UTC for sore throat and enlarged tonsils.  She was told that she did not have strep.  No other diagnosis at that time.   She continued to have fatigue and sore throat for the week March 8th.   On March 14th, she went to UTC with sore throat, tonsils were visibly enlarged and blotchy.  She was diagnosed with Mononucleosis.
Information has been received from a medical assistant referring to a 18 year old patient of unknown gender. Information regarding concurrent conditions and medical history was not provided. On 05-MAY-2015 the patient was vaccinated with PROQUAD (Merck), lot # reported as: K014799, exp. date unknown, 0.5 ml, subcutaneous (dose number and application site were not reported) (inappropriate schedule of drug administration). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
3-12-21: left eye discharge w/ pus, body aches, fever. 3-12-21: chills, sweating at night. 3-16-21: feeling mouth is twisting at night, cannont feel left side of face. 3-17-21: Face droopy, fever, tense muscles, went to ER same day.
No additional AE's or PQC's noted; Caller reported a temperature excursion/ which was administered to multiple patients; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 30-MAR-2021, the patient was vaccinated with improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 1 dosage form orally, lot # 1688825 and expiration date 24-NOV-2021, administered as prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion of 47.7 degree fahrenheit (°F) for 8 minutes, 54 °F for 28 minutes and 47.8 °F for 12 minutes. Previous temperature excursions were reported with the following details: 61.9 °F for 9 hours and 21 minutes and 56.3 °F for 4 hours and 27 minutes.  The call was made due to a digital data logger. No adverse symptoms were reported. This is one of several cases from the same reporter; Sender's Comments:  US-009507513-2104USA003253: US-009507513-2104USA003130: US-009507513-2104USA003255:
Heart palpitations, tachycardia, disturbed sleep (every night) due to atrial fibrillation, severely impacted physical activity (unable to perform basic daily routine). Symptoms worsened in August - October and are ongoing with no explanation. 3 Covid tests from May to Sep were all negative.
Stomach pretty covered. Low grade fever. Some on arms. Few on legs, quite pronounced. 5 or 6 days total.
Pt recv vax on 8/11/98; on same day pt exp LA redness, bruising & swelling (1.5 x 1.5 cm);tx=Tylenol/Ibuprofen
energy level dropped; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (energy level dropped) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (energy level dropped). At the time of the report, ASTHENIA (energy level dropped) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  It was reported that patient's energy level dropped for about 3 days.  It was not reported if the patient was received any corrective treatment for the event.
Patient stated within one to two days after getting the shot she had intense pain, swelling, and hot redness at the vaccine location. She cannot recall exactly where she received the vaccine yet she expressed concern as she believes it was a little lower that it should have been. She came to see us over a week later to have us assess the site as it was still swollen and she could not lift her arm above her chest level due to intense pain. I advised her to seek medical care and continue her treatment with ibuprofen and switch to ice pack from a hot pack.
After the first vaccine, at 5am the next morning, my blood pressure dropped to 90/65 causing my vision to blackout/feel like I was going to faint, and feel like I was going to throw up when standing. I stayed flat in bed the whole day and the second day after (4/8/21), it subsided. After the second vaccine on 4/27/21, it was a much more significant response. This occurred again at about 5am the morning after the vaccine (4/28, less than 12 hours after), my blood pressure began to fall and I was experiencing orthostatic hypotension again.  On 4/29 significant body aches and pains (flu like symptoms set in). On Friday 4/30/21, I woke up, and without moving, the room was spinning, I felt like I was going to throw up, had bad headaches, and I was extremely dizzy. I took my blood pressure at it was 80/50. I could not stand or sit up, I had to lay flat with my legs propped up to keep blood flow to my head. I missed work from 4/28-5/1 as I was so hypotensive and symptomatic. I called my cardiologists office on the afternoon of 4/30 to get their advice and confirm that I should NOT take my hypertension and tachycardia medications that night (verapamil and metoprolol). The nurse advised me not to take them that day and to go to the hospital since I was so symptomatic. My mom, a cardiac care nurse, was with me at home, so I decided to stay home and only go in if it dropped any lower. The next day (Saturday) it began to normalize to around 110/70 and Sunday I was 120/80. I did not take any medication Saturday or Sunday, because I did not want my pressure to go low again. Monday I contacted my cardiologists office again, because I was still reading normal with no meds in my system, but was beginning to get chest pains related to the withdrawal from metoprolol, so they had me take the verapamil and metoprolol in normal doses Monday afternoon. Tuesday, I woke up low again (100/60) and had to call off work again. I contacted my cardiologist again, and he advised me to stop verapamil until my pressure got more high and I needed it again and called in a lower dose of my metoprolol (half the strength of what I was taking). It is now 5/9/21 and my pressure is still about 125/85, so  I have not been able to resume the verapamil and am still on the half strength metoprolol.
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concomitant therapies, concurrent conditions, historical drugs or allergies were not reported. On 31-MAY-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot number N025428 and expiry date 19-JUN-2020 (strength, dose, route and frequency were not reported) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of 36 to 46 degrees Fahrenheit (°F) (35.9 °F) for a time frame of 16 hours and 22 minutes. There was a previous temperature excursion at 36°F to 46°F for 10 hours and 25 minutes; and 32°F up to 35°F for 3 hours and 15 minutes, as recorded by a data logger. There was no adverse effect reported. No product quality complaint was involved. This is one of thirteen reports from the same reporter. Sender's Comments: US-009507513-1811USA008122: US-009507513-1811USA004452: US-009507513-1811USA008124: US-009507513-1811USA008125: US-009507513-1811USA008126: US-009507513-1811USA008127: US-009507513-1811USA008128: US-009507513-1811USA008129: US-009507513-1811USA008121: US-009507513-1811USA008120: US-009507513-1811USA008119: US-009507513-1811USA008123.
Slight fever; Chills; Headache; Fatigue; Pain in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 11Apr2021 at 10:45(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to food, medications or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on 22Mar2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021 at 15:30 the patient experienced slight fever, chills, headache, fatigue and pain in left arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, slight fever, chills, headache, fatigue and pain in left arm was recovered on unknown date on Apr2021.  No follow-up attempts are possible. No further information is expected.
Rash lower back and center front and across chest, left arm at site of injection.  Mild itching.  After about 5 days the rash went away and so did the itching.
Pain in left arm for 36 hours; Diarrhea twice a morning every day; Tenderness at back of neck/base of neck/clavicle; Swollen lymph nodes on left side; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mucocutaneous lymph node syndrome (at the age of 4 years).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. On 15-Jan-2021, PAIN (Pain in left arm for 36 hours), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) had resolved. On 22-Jan-2021, DIARRHOEA (Diarrhea twice a morning every day) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient uses unspecified allergic concomitant medications.
presented with cough x10 days; sob x2 days; dx Covid PNA; Labs: D-dimer 0.90; CRP 14.20; Ferritin 198 CXR: Bibasilar patchy opacities may represent pneumonia Tx: Steroids, lovenox, singulair, zinc (remdesivir not indicated due to timing of onset)   D/C on home O2